Second senior Chinese diplomat detained for questioning, sources say
Sun Haiyan, a senior diplomat and former ambassador to Singapore, was detained in early August around the time Liu Jianchao, widely seen as a potential foreign minister candidate, was taken in for questioning, two of the people said.
Sun, the first woman to serve as a deputy head of the Communist Party's International Department, was detained by Chinese authorities in connection with the questioning of Liu, the sources said.
None of the sources knew the basis of the questioning of either diplomat. The sources requested anonymity because of the sensitivity of the matter.
The detention of Liu, who leads the International Department, marked the highest-level disappearance of a diplomat since China ousted its former foreign minister and President Xi Jinping's protege, Qin Gang, in 2023, following an unexplained public absence.
His detention followed a work trip to Singapore, South Africa and Algeria. His house was searched in early August.
The disappearance of Sun alongside the highly visible Liu, adds to questions about China's foreign policy establishment at a time of rising tensions with Washington around trade and geopolitical influence.
China's State Council Information Office, which handles media queries for the government, and the International Department did not immediately respond to Reuters requests for comment.
Reuters could not verify if both Sun and Liu were still being detained. Neither could be reached for comment.
Both their profiles remain on the International Department's website.
Sun's last public appearance was on August 1, when she attended a reception hosted by Nepal's embassy in Beijing.
Sun, 53, was stationed in Singapore between May 2022 and July 2023. When she left her post, she hosted a 500-person reception at a luxury Singapore hotel, according to Chinese news reports.
She joined the International Department in 1997, where she served in a wide range of roles, including spokesperson and head of the bureau responsible for ties with Southeast Asian countries. She also served as a district Party Committee official in the city of Zibo, Shandong province, in 2008.
Originally from Hebei province, Sun holds a doctorate in law from Peking University, having also studied at Japan's Kyushu University.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
10 minutes ago
- Bloomberg
Hong Kong Democracy Activist Ted Hui Granted Asylum in Australia
Hong Kong pro-democracy activist Ted Hui said he's been granted asylum in Australia, more than four years after he left the city to evade national security charges. The former lawmaker said in a post on Facebook that he'd received written notice from the Department of Home Affairs granting protection visas to him, his wife, children and parents. 'This decision reflects values of freedom, justice, and compassion that my family will never take for granted,' he said.
Yahoo
3 hours ago
- Yahoo
Hong Kong democracy activist granted asylum after fleeing to Australia
Australia has granted asylum to Hong Kong pro-democracy activist Ted Hui, he said in a social media post, a move likely to raise tensions with China. Mr Hui, a former Hong Kong parliamentarian, fled the city four years ago and first arrived in Europe in December 2020. In March 2021, he became the first Hong Kong politician to be granted a special travel exemption during coronavirus restrictions to enter Australia. In 2022, Mr Hui was convicted in Hong Kong in his absence on charges of taking part in a pro-democracy protest and was sentenced to three-and-a-half years in jail. On Saturday, Mr Hui said he had 'received formal notification from the Australian Department of Home Affairs that I have been granted asylum in Australia'. In an emotional post, he said: 'When people around me say 'congratulations' to me, although I politely thank them, I can't help but feel sad in my heart. How to congratulate a political refugee who misses his hometown?" "If it weren't for political persecution, I would never have thought of living in a foreign land. Immigrants can always return to their home towns to visit relatives at any time; Exiles have no home." Mr Hui, who is now an Adelaide-based lawyer, said he identifies more closely with Australia today than he did when he arrived four years ago, and said he 'believe[s] asylum also carries responsibility'. 'My family and I are determined to give back to Australia in every way we can—through our work, our civic engagement, and our commitment to the values of democracy and freedom,' he said. The Australian government's 'decision reflects values of freedom, justice, and compassion that my family will never take for granted,' he added. The 42-year-old father, a prominent critic of both the Hong Kong government and Beijing, was one of several overseas activists hit with Hong Kong police bounties of HK$1m (about £94,281) each in 2023. While these bounties have drawn condemnation from Western governments, they are largely viewed as symbolic gestures, since most of those targeted live in countries with little prospect of extradition to Hong Kong or mainland China. In Adelaide, where Mr Hui is based, the campaign against him has taken a more personal turn. Earlier this year, his colleagues received an anonymous letter offering $203,000 Australian dollars for information about his movements and family. Around the same time, fake pamphlets portraying Mr Hui as a pro-Israel lawyer bent on 'waging war' against Islamic terrorism were reportedly circulated to local mosques, apparently in an effort to threaten and discredit him. At that time, Mr Hui blamed 'the Chinese regime's long arm' for harassing him internationally. Mr Hui concluded his post by requesting the Australian government not to forget those still suffering in Hong Kong's prisons, mentioning a number of activists including Jimmy Lai, the media mogul and British citizen who is currently on trial in the city. 'Australia must do more to rescue them and to speak up for their humanity,' Mr Hui said. 'Its stance matters internationally, and its protection of Hongkongers sets a precedent for other democracies.' The Hong Kong government said in a statement that it was 'against the harbouring of criminals in any form by any country'. Australian prime minister Anthony Albanese visited Beijing last month as part of his administration's years-long push to improve ties with China, Australia's number one export market. The relationship suffered a number of blows during the pandemic as both countries hit each other with punitive trade tariffs. During the visit, Xi Jinping said the China-Australia relationship 'has risen from the setbacks and turned around, bringing tangible benefits to the Chinese and Australian peoples'.
New York Times
3 hours ago
- New York Times
China's Biotech Is Cheaper and Faster
Just outside of Shanghai, in the city of Wuxi, China is building its future of medicine — a booming biotechnology hub of factories and laboratories where global pharmaceutical companies can develop and manufacture drugs faster and cheaper than anywhere else. Amid the Trump administration's tariffs on China, I figured manufacturing hubs like this one would be wracked with anxiety. But when I visited Wuxi in April, government officials insisted that its research hub was flourishing. They were proud to tell me about their superstar labs and companies that are continuing to thrive. The fact that Chinese biotechnology stocks have surged over 60 percent since January seems to bolster this claim. The city's researchers certainly seemed positioned to be busy for decades. In its quest to dethrone American dominance in biotech, China isn't necessarily trying to beat America at its own game. While the U.S. biotech industry is known for incubating cutting-edge treatments and cures, China's approach to innovation is mostly focused on speeding up manufacturing and slashing costs. The idea isn't to advance, say, breakthroughs in the gene-editing technology CRISPR; it's to make the country's research, development, testing and production of drugs and medical products hyperefficient and cheaper. As a result, China's biotech sector can deliver drugs and other medical products to customers at much cheaper prices, including inexpensive generics. These may not be world-changing cures, but they are treatments that millions of people around the world rely on every day. And as China's reach expands, the world will soon have to reckon with a new leader in biotech and decide how it wants to respond. One such company that embodies the Chinese approach to biotech is Wuxi AppTec. It's a one-stop shop for pharmaceutical research and development, streamlining everything from early-stage drug discovery to young scientist recruitment and medication production. The company, whose clients have included Chinese firms like Innovent and Jiangsu Hengrui, as well as American and European drugmakers like Pfizer, GlaxoSmithKline and AstraZeneca, was involved in, by one estimate, a quarter of the drugs used in the United States, including blockbuster cancer drugs. Though the Chinese government bargains hard with both foreign and domestic pharmaceutical companies to provide products at the right price in exchange for market access, the low prices that Chinese consumers pay are ultimately the result of Chinese biotech companies' ability to test and manufacture drugs at a pace far faster than their American counterparts. So far, American biotech giants don't seem to mind the competition, since their own use of companies like Wuxi AppTec allows them to dedicate more of their money to breakthrough research. Want all of The Times? Subscribe.
